An introduction to the free radical hypothesis in Parkinson's disease.
about
Increased apoptosis, p53 up-regulation, and cerebellar neuronal degeneration in repair-deficient Cockayne syndrome miceOxidative stress associated with neuronal apoptosis in experimental models of epilepsyProtective effects of atypical antipsychotic drugs on PC12 cells after serum withdrawalIron and mechanisms of emotional behavior.Curcumin reduces alpha-synuclein induced cytotoxicity in Parkinson's disease cell model.Nanoparticle and iron chelators as a potential novel Alzheimer therapy.Ginsenoside Rg1 prevents cognitive impairment and hippocampus senescence in a rat model of D-galactose-induced aging.Excitotoxicity, oxidative stress, and the neuroprotective potential of melatonin.Nanoparticle delivery of transition-metal chelators to the brain: Oxidative stress will never see it coming!Apoptosis modulators in the therapy of neurodegenerative diseases.Reactive oxygen/nitrogen species and their functional correlations in neurodegenerative diseases.Antioxidant therapy in ALS.Ethanol extract of Scutellaria baicalensis Georgi prevents oxidative damage and neuroinflammation and memorial impairments in artificial senescense mice.Mitochondrial genome analysis of primary open angle glaucoma patientsMelatonin in mitochondrial dysfunction and related disordersRole of metal dyshomeostasis in Alzheimer's disease.Intrathecal infusion of hydrogen-rich normal saline attenuates neuropathic pain via inhibition of activation of spinal astrocytes and microglia in rats.Therapeutic potential of melatonin and its analogs in Parkinson's disease: focus on sleep and neuroprotection.Pro-apoptotic gene expression mediated by the p38 mitogen-activated protein kinase signal transduction pathwayReactive oxygen species (ROS) are involved in enhancement of NMDA-receptor phosphorylation in animal models of painRopinirole in the treatment of Parkinson's disease.Dietary supplementation with fruit polyphenolics ameliorates age-related deficits in behavior and neuronal markers of inflammation and oxidative stress.Antinociceptive effects of intraperitoneal and intrathecal vitamin e in the rat formalin testMitochondrial oxidative damage in aging and Alzheimer's disease: implications for mitochondrially targeted antioxidant therapeuticsFruit polyphenols and their effects on neuronal signaling and behavior in senescence.The role of oxidative stress, metabolic compromise, and inflammation in neuronal injury produced by amphetamine-related drugs of abuse.Metal chelators coupled with nanoparticles as potential therapeutic agents for Alzheimer's diseaseDrug delivery strategies for Alzheimer's disease treatment.Nanotherapeutics for Alzheimer's disease (AD): Past, present and future.Melatonin antioxidative defense: therapeutical implications for aging and neurodegenerative processes.Oxidative and nitrative alpha-synuclein modifications and proteostatic stress: implications for disease mechanisms and interventions in synucleinopathies.Blueberry supplemented diet: effects on object recognition memory and nuclear factor-kappa B levels in aged rats.Isolation stress exposure and consumption of palatable diet during the prepubertal period leads to cellular changes in the hippocampus.Selegiline increases heme oxygenase-1 expression and the cytotoxicity produced by dopamine treatment of neuroblastoma SK-N-SH cells.Hydrogen peroxide induces intracellular calcium overload by activation of a non-selective cation channel in an insulin-secreting cell line.Copper/zinc superoxide dismutase expression in the human central nervous system. Correlation with selective neuronal vulnerability.Simple isatin derivatives as free radical scavengers: Synthesis, biological evaluation and structure-activity relationshipGlutamyl cysteine synthetase catalytic and regulatory subunits localize to dopaminergic nigral neurons as well as to astrocytes.Different action on dopamine catabolic pathways of two endogenous 1,2,3,4-tetrahydroisoquinolines with similar antidopaminergic properties.Studies, using in vivo microdialysis, on the effect of the dopamine uptake inhibitor GBR 12909 on 3,4-methylenedioxymethamphetamine ('ecstasy')-induced dopamine release and free radical formation in the mouse striatum.
P2860
Q24682525-6D0B6E14-B6DA-4194-85DD-68213AB27E01Q26823122-EDF6C5D5-BF3C-4251-8D2D-06316A8D4587Q28582269-22665D5F-1C53-4A8F-BDBE-23AE182B53DDQ30399941-0DAEEF1D-7551-432C-8E59-B88B253B992BQ33569173-A3A73604-6377-421C-9F5B-A3AFE42CE01BQ33720596-D167D24D-7EB3-4FA3-BA35-0318CBB85DD1Q33825890-16F383C5-70D8-4B52-8405-E4B52E90DA4CQ33834167-2325ED1B-16E3-4A5A-9A39-560DD792A7EFQ33957213-1E8958E5-B5D8-4E06-A659-390E6EFA9B66Q34074800-999543E4-9F88-4AFA-9FD0-072A0E7A4B3CQ34243986-7E3EC3DC-8D3E-43F7-92F3-A614967A9984Q34315679-78B81266-1671-4949-9CCF-DEF8D7E7B57FQ34586040-A8BA5E43-1EBF-446E-8F99-4AA47439B55AQ34935899-881B217A-9DAD-4B22-917D-F5BD18317520Q35001051-97C9966D-0802-4293-9223-BE5CF36C9149Q35051952-B01A3EC1-4088-4CC3-B630-C3C2B98B160AQ35173285-9D344129-CE7B-4EFF-8377-E4D26583E1B9Q35276597-1ACAB15B-FF26-43AA-A1D0-405732E65056Q35933272-12FD36FC-2326-4B7D-9007-A4E8B920E785Q36102465-E08DE5B5-F96A-4E8F-8146-E55CEEC3C28DQ36181342-F66D89FF-6E80-4435-8944-8786ACED333BQ36272920-0613A32E-4E0C-425B-98B5-D18425E344E3Q36310253-6F3F26A1-C5A9-40E6-B6C4-5DC203BA4331Q36626374-68841D15-409B-41DB-9A9B-EBCB2BEA7309Q36802182-342D9C76-8ECA-4090-8088-BFAF087EA93FQ37245998-3CE88904-F90C-46DD-B1E6-CA71E1A0E44FQ37428097-B64F2050-399D-48D2-819B-34015B675222Q37851509-0FEE7C6A-41B8-4A04-BBBE-55F64EDB7B5AQ37948993-F49F4DF7-A7E8-4B1E-A776-AE93D379891FQ38022179-035828A8-2F3A-42C7-B9BE-535D2CBC4C34Q38085689-28C55EC6-A7E5-4031-8538-F6E223C19C9CQ38516857-A12DA48E-D45E-46C9-B3B9-FEF60C0AF750Q39297550-5EF92456-3010-4603-BE27-CC13B18F7E71Q40533572-69C920DC-5594-45A6-B7F0-D24B9B87E8BAQ40984637-10EF66A1-73CA-47C1-96BE-739703897546Q41890153-5BF1F6D8-9BC8-41E7-B46A-74347D23FB54Q42855274-1B313539-C97C-4782-822E-6BC5CDEB71D6Q43565738-F47E5F5F-FAFB-4850-ADAE-EB2B4477C853Q43658596-C76503A9-409A-4528-AA31-DC20A7AC016CQ44028686-19C8BF3F-6489-4E14-937F-54067BBF480E
P2860
An introduction to the free radical hypothesis in Parkinson's disease.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
An introduction to the free radical hypothesis in Parkinson's disease.
@ast
An introduction to the free radical hypothesis in Parkinson's disease.
@en
type
label
An introduction to the free radical hypothesis in Parkinson's disease.
@ast
An introduction to the free radical hypothesis in Parkinson's disease.
@en
prefLabel
An introduction to the free radical hypothesis in Parkinson's disease.
@ast
An introduction to the free radical hypothesis in Parkinson's disease.
@en
P2860
P356
P1433
P1476
An introduction to the free radical hypothesis in Parkinson's disease.
@en
P2093
P2860
P356
10.1002/ANA.410320703
P478
P577
1992-01-01T00:00:00Z